4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001415889-25-001853
President and CEO acquired 109,459 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2024-12-03 | Option exercise | +91,750 | $0.53 | $48,628 | 534,210 | D |
| Mack David Henry President and CEO | 2025-01-03 | Option exercise | +17,709 | $0.53 | $9,386 | 551,919 | D |
| Derivatives | |||||||
| Mack David Henry President and CEO | 2024-12-03 | Option exercise · Employee Stock Option (right to buy) | −91,750 | 17,709 | D | ||
| Mack David Henry President and CEO | 2025-01-03 | Option exercise · Employee Stock Option (right to buy) | −17,709 | 0 | D | ||
Loading xslF345X05/form4-01222025_090129.xml…